122 related articles for article (PubMed ID: 31638746)
1. The effect of the population-based cervical cancer screening program on 5-year survival in cervical cancer patients in Lower Silesia.
Zielecka-Dębska D; Błaszczyk J; Błaszczyk D; Szelachowska J; Lichoń K; Maciejczyk A; Matkowski R
Adv Clin Exp Med; 2019 Oct; 28(10):1377-1383. PubMed ID: 31638746
[TBL] [Abstract][Full Text] [Related]
2. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
3. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
[TBL] [Abstract][Full Text] [Related]
4. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
5. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
Nowakowski A; Wojciechowska U; Wieszczy P; Cybulski M; Kamiński MF; Didkowska J
Eur J Epidemiol; 2017 Jun; 32(6):529-532. PubMed ID: 28780640
[TBL] [Abstract][Full Text] [Related]
6. Population-based organized cervical cancer screening pilot program in France.
Hamers FF; Duport N; Beltzer N
Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
[TBL] [Abstract][Full Text] [Related]
7. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
8. [Cervical cancer incidence and mortality rates including the screening program results in the Podkarpackie Region between 1999-2010].
Karczmarek-Borowska B; Grsdalska-Lampart M
Ginekol Pol; 2013 Nov; 84(11):930-7. PubMed ID: 24455849
[TBL] [Abstract][Full Text] [Related]
9. Community-based intervention for cervical cancer screening uptake in a semi-urban area of Pokhara Metropolitan, Nepal (COBIN-C): study protocol for a cluster-randomized controlled trial.
Shrestha AD; Neupane D; Ghimire S; Campbell C; Kallestrup P
Trials; 2021 Jan; 22(1):94. PubMed ID: 33499911
[TBL] [Abstract][Full Text] [Related]
10. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
13. [The use of interactive medical data transfer to increase effectiveness of a mass screening program].
Knapp P; Zbroch T; Knapp P
Ginekol Pol; 2004 Nov; 75(11):896-903. PubMed ID: 15754581
[TBL] [Abstract][Full Text] [Related]
14. [Adherence to cervical cancer screening in an Italian SLE cohort].
Tani C; Carli L; Mosca M; Baldini C; Consensi A; Doveri M; Talarico R; Bombardieri S
Reumatismo; 2011 Mar; 63(1):11-7. PubMed ID: 21509345
[TBL] [Abstract][Full Text] [Related]
15. Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.
Basta T; Knapp P; Blecharz P; Bodnar L; Gawron I; Babczyk D; Piróg M; Kluz T; Markowska A; Horbaczewska A; Jach R
PLoS One; 2019; 14(1):e0209901. PubMed ID: 30703105
[TBL] [Abstract][Full Text] [Related]
16. Reporting rates for cervical screening in the Szczecin Region during the period 2007-2010.
Owoc A; Cveijć R; Koprowicz A; Sygit K; Fronczak A; Bojar I
Ann Agric Environ Med; 2012; 19(4):686-91. PubMed ID: 23311790
[TBL] [Abstract][Full Text] [Related]
17. Survival in women diagnosed with breast and cervical cancer in Poland – compared to European countries, based on CONCORD - 3 Programme.
Gliniewicz A; Zielińska A; Kwiatkowska K; Dudek-Godeau D; Bielska–Lasota M
Przegl Epidemiol; 2018; 72(4):499-508. PubMed ID: 30810005
[TBL] [Abstract][Full Text] [Related]
18. Modifiable barriers to cervical cancer screening adherence among working women in Mexico.
Wall KM; Rocha GM; Salinas-Martínez AM; Baraniuk S; Day RS
J Womens Health (Larchmt); 2010 Jul; 19(7):1263-70. PubMed ID: 20509792
[TBL] [Abstract][Full Text] [Related]
19. Cervical carcinoma in the European Union: an update on disease burden, screening program state of activation, and coverage as of March 2014.
Altobelli E; Lattanzi A
Int J Gynecol Cancer; 2015 Mar; 25(3):474-83. PubMed ID: 25695550
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer trend in the Republic of Kazakhstan and attitudes towards cervical cancer screening in urban and rural areas.
Zhetpisbayeva I; Rommel A; Kassymbekova F; Semenova Y; Sarmuldayeva S; Giniyat A; Tanatarova G; Dyussupova A; Faizova R; Rakhmetova V; Glushkova N
Sci Rep; 2024 Jun; 14(1):13731. PubMed ID: 38877051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
